Pulmonary, Cardiovascular, and Neurological Consequences of Systemic Hypoxia: An Integrative Multidisciplinary Review
DOI:
https://doi.org/10.64784/219Keywords:
Hypoxia, Hypoxemia, Pulmonary Dysfunction, Cardiovascular Disease, Neurological Injury, Pulmonary Hypertension, Oxidative Stress, Neuroinflammation, Endothelial Dysfunction, Brain-Lung Interaction, Oxygen Deprivation, Critical Care, Systemic Inflammation, Chronic Obstructive Pulmonary Disease, Obstructive Sleep ApneaAbstract
Hypoxia is a complex multisystemic condition characterized by insufficient oxygen availability at the tissue level, producing progressive dysfunction involving the pulmonary, cardiovascular, and neurological systems. Although traditionally associated with respiratory failure, contemporary evidence demonstrates that hypoxia activates interconnected physiological, inflammatory, vascular, metabolic, and neurological pathways capable of generating widespread systemic injury. The objective of this review was to analyze the principal mechanisms through which hypoxia contributes to pulmonary, cardiovascular, and neurological dysfunction, emphasizing the integrated interactions between these systems and their clinical implications in modern medicine. This review was developed using a structured narrative methodology based on scientific literature indexed in international databases including PubMed, Scopus, Google Scholar, Europe PMC, Elsevier, and SpringerLink. The investigation integrated evidence from pulmonology, cardiology, neurology, critical care medicine, and vascular physiology in order to evaluate the systemic consequences of acute, chronic, and intermittent hypoxia. Special attention was given to molecular mechanisms such as hypoxia-inducible factor activation, oxidative stress, endothelial dysfunction, autonomic imbalance, mitochondrial injury, inflammatory cytokine release, and vascular remodeling. The findings demonstrate that pulmonary dysfunction initiates hypoxemia through mechanisms including ventilation-perfusion mismatch, diffusion impairment, hypoventilation, and shunt physiology. Cardiovascular adaptation initially attempts to preserve oxygen delivery through sympathetic activation and pulmonary vasoconstriction; however, prolonged hypoxic exposure contributes to pulmonary hypertension, right ventricular overload, endothelial dysfunction, arrhythmogenic instability, and impaired systemic perfusion. Neurological consequences include neuroinflammation, excitotoxicity, cognitive impairment, cerebral autoregulatory dysfunction, and hypoxic-ischemic injury due to the high metabolic vulnerability of neuronal tissue. Intermittent hypoxia, particularly in obstructive sleep apnea, was associated with substantial cardiovascular and neurocognitive consequences related to oxidative stress and autonomic dysregulation.
References
1. M. Sarkar, N. Niranjan, and P. K. Banyal, “Mechanisms of hypoxemia,” Lung India, vol. 34, no. 1, pp. 47–60, 2017, doi: 10.4103/0970-2113.197116.
2. B. S. Bhutta, A. Alghoula, and I. Berim, “Hypoxia and Hypoxemia,” in StatPearls, Treasure Island, FL: StatPearls Publishing, 2024.
3. P. S. Chen et al., “Pathophysiological implications of hypoxia in human diseases,” J. Biomed. Sci., vol. 27, no. 1, p. 63, 2020, doi: 10.1186/s12929-020-00658-7.
4. G. L. Semenza, “Hypoxia-inducible factor 1 and cardiovascular disease,” Annu. Rev. Physiol., vol. 76, pp. 39–56, 2014, doi: 10.1146/annurev-physiol-021113-170322.
5. Y. Zhao et al., “Hypoxia-induced signaling in the cardiovascular system,” Signal Transduct. Target. Ther., vol. 8, p. 431, 2023, doi: 10.1038/s41392-023-01652-9.
6. B. D. Kent, S. Mitchell, and W. T. McNicholas, “Hypoxemia in patients with COPD: cause, effects, and disease progression,” Int. J. Chron. Obstruct. Pulmon. Dis., vol. 6, pp. 199–208, 2011, doi: 10.2147/COPD.S10611.
7. A. Agustí et al., “Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary,” Eur. Respir. J., vol. 61, no. 4, 2023, doi: 10.1183/13993003.00239-2023.
8. M. Humbert et al., “2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension,” Eur. Heart J., vol. 43, no. 38, pp. 3618–3731, 2022, doi: 10.1093/eurheartj/ehac237.
9. S. Rosenkranz et al., “Systemic consequences of pulmonary hypertension and right-sided heart failure,” Circulation, vol. 141, no. 8, pp. 678–693, 2020, doi: 10.1161/CIRCULATIONAHA.116.022362.
10. A. Zangiabadi et al., “Pulmonary hypertension and right heart dysfunction in chronic lung disease,” BioMed Res. Int., vol. 2014, p. 739674, 2014, doi: 10.1155/2014/739674.
11. ARDS Definition Task Force, “Acute respiratory distress syndrome: The Berlin Definition,” JAMA, vol. 307, no. 23, pp. 2526–2533, 2012, doi: 10.1001/jama.2012.5669.
12. M. A. Matthay et al., “A new global definition of acute respiratory distress syndrome,” Am. J. Respir. Crit. Care Med., vol. 209, no. 1, pp. 37–47, 2024, doi: 10.1164/rccm.202303-0558WS.
13. L. Evans et al., “Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021,” Intensive Care Med., vol. 47, no. 11, pp. 1181–1247, 2021, doi: 10.1007/s00134-021-06506-y.
14. J. Helms et al., “Oxygen therapy in acute hypoxemic respiratory failure,” Ann. Intensive Care, vol. 14, p. 22, 2024, doi: 10.1186/s13613-024-01367-2.
15. M. Ziaka and S. Exadaktylos, “Brain–lung interactions and mechanical ventilation in patients with isolated brain injury,” Crit. Care, vol. 25, p. 358, 2021, doi: 10.1186/s13054-021-03778-8.
16. A. A. Chacón-Aponte et al., “Brain-lung interaction: a vicious cycle in traumatic brain injury,” Acute Crit. Care, vol. 37, no. 2, pp. 175–184, 2022, doi: 10.4266/acc.2021.01555.
17. M. Lacerte, E. Hays Shapshak, and M. Mesfin, “Hypoxic Brain Injury,” in StatPearls, Treasure Island, FL: StatPearls Publishing, 2023.
18. R. Areza-Fegyveres et al., “Cognition and chronic hypoxia in pulmonary diseases,” Dement. Neuropsychol., vol. 4, no. 1, pp. 14–22, 2010, doi: 10.1590/S1980-57642010DN40100003.
19. Y. Yeghiazarians et al., “Obstructive sleep apnea and cardiovascular disease: A scientific statement from the American Heart Association,” Circulation, vol. 144, no. 3, pp. e56–e67, 2021, doi: 10.1161/CIR.0000000000000988.
20. C. D. Turnbull, D. J. Sen, and J. R. Stradling, “Intermittent hypoxia, cardiovascular disease and obstructive sleep apnoea,” J. Thorac. Dis., vol. 10, suppl. 1, pp. S33–S39, 2018, doi: 10.21037/jtd.2017.10.33.
